Skip to main content Accessibility help
×
Hostname: page-component-7c8c6479df-8mjnm Total loading time: 0 Render date: 2024-03-27T13:09:16.263Z Has data issue: false hasContentIssue false

14 - Pre-implantation genetic testing

from SECTION 2 - THE EMBRYO

Published online by Cambridge University Press:  05 June 2014

Peter Braude
Affiliation:
Guy’s and St Thomas’ NHS Trust and GKT School of Medicine
Jan Grace
Affiliation:
GKT School of Medicine
Tarek El Tockhy
Affiliation:
GKT School of Medicine
Hilary Critchley
Affiliation:
University of Edinburgh
Iain Cameron
Affiliation:
University of Southampton
Stephen Smith
Affiliation:
Lee Kong Chian School of Medicine
Get access

Summary

Introduction

Since its first clinical use, pre-implantation genetic testing (PGT) has become increasingly available as a method of detecting genetic disorders before pregnancy is established. Based on a difference of purpose, PGT can be classified as either pre-implantation genetic diagnosis (PGD) or pre-implantation genetic screening (PGS). PGD was established in the early 1990s as an alternative to prenatal diagnosis (PND) and termination of pregnancy. PGD describes the testing of oocytes or embryos from patients who have a significant risk of conceiving a pregnancy affected by a known recurrent genetic disorder, in order to preselect for transfer only those embryos found not to carry the disorder. PGS, on the other hand, aims to improve the outcome of assisted reproductive technology (ART) treatment for the subfertile by testing for a number of the more frequent chromosome aneuploidies in an attempt to improve implantation and reduce the incidence of miscarriage. It is estimated that worldwide, more than 1000 children have been born following PGT. The clinical application of PGT is expanding into new areas, creating novel ethical and practical dilemmas.

In order for a pre-implantation genetic test to be performed, a representative sample of the embryo is required. A single cell can be removed from a late cleavage stage embryo (8—16 cells), or a few cells may be taken from the trophectoderm of a blastocyst, or one or both of the polar bodies can be removed from the unfertilised egg or early zygote.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×